A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
NCT06364696
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
175
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
ASP4396
Sponsor
Astellas Pharma Inc